Push to split MMR vaccine raises fears of undoing decades of progress and triggering outbreaks

President Trump’s proposal to separate the MMR vaccine threatens to reverse over 50 years of disease control and risks a resurgence of measles, mumps, and rubella outbreaks, experts warn.

President Donald Trump’s push to split the measles, mumps and rubella vaccine into separate shots would break with a public health tool that has been in place for more than half a century and helped drive down three once-feared childhood diseases. The MMR vaccine was built in part from a virus sample taken from Maurice Hilleman’s own daughter after she fell ill with mumps in 1963, a story that has become part of vaccine history and the Merck scientist’s legacy. The Smithsonian’s Antibody Initiative says the combined shot, first licensed in 1971, has saved millions of lives worldwide.

That history matters because the three diseases are not interchangeable in their dangers. Before vaccination, measles caused tens of thousands of hospitalisations in the United States each year, along with encephalitis and hundreds of deaths, while rubella could lead to devastating birth defects when pregnant women were infected. Mumps was the leading cause of childhood deafness before the vaccine era. The point of the combined shot was not convenience alone, but simple public health logic: one appointment, one injection, fewer chances for a child to go unprotected.

The safety record is also central to the current debate. Large studies have repeatedly found no link between the MMR vaccine and autism, and there is no evidence that giving several vaccines together raises autism risk. The article also notes that thimerosal, a preservative once used in some vaccines but no longer in routine childhood shots in the United States, has not been shown to cause harm despite years of claims to the contrary.

Japan offers a warning about what can happen when a combined MMR programme collapses. According to The Japan Times, the country suspended its MMR vaccine in 1993 after concerns about aseptic meningitis, leaving only separate measles, mumps and rubella doses. Vaccination coverage later slipped, and Japan saw continued mumps transmission, a large measles outbreak in 2001 and a rubella epidemic in 2012. The same reporting says a new MMR vaccine was approved by an expert panel in March 2026, although it is not yet available. The report adds that Japan was later verified as having eliminated measles in 2015 and rubella in 2025.

In the US, no single-dose measles, mumps or rubella vaccines are currently marketed, and it is unclear whether that would change if federal policy pushed manufacturers to separate the combined shot. Public health experts warn that any drop in uptake could worsen the ongoing measles outbreak. A Stanford modelling study cited in the article estimated that measles could become endemic again at current vaccination levels and that a 10% fall in MMR coverage could eventually lead to 11 million cases over 25 years. On that reading, the risk is not theoretical: it is a return to diseases that modern vaccination largely pushed out of daily life.